Intervention News

CHICAGO — Compared with usual care, a system of electronic provider notification more often enabled patients diagnosed with severe aortic stenosis to have aortic valve replacement within 1 year, researchers reported.

CHICAGO — For patients with symptomatic aortic regurgitation at high surgical risk, a transcatheter aortic valve replacement system exceeded safety and performance goals, according to results of the ALIGN-AR trial.

Living along coastal areas in the United States that had higher levels of microplastics in the ocean was strongly associated with an increased risk for disability vs. living in coastal areas with lower levels, preliminary data show.

CHICAGO — The first trial to evaluate use of an SGLT2 inhibitor in people undergoing transcatheter aortic valve replacement showed benefit with dapagliflozin compared with standard care alone, including in older patients.

CHICAGO — Routine cerebral embolic protection did not reduce the incidence of stroke at 72 hours in patients undergoing transcatheter aortic valve replacement, according to results of the BHF PROTECT-TAVI trial.

CHICAGO — Among patients with severe aortic stenosis at low surgical risk, transcatheter aortic valve replacement and surgery conferred similar rates of death and disabling stroke at 5 years, new data from the Evolut Low Risk Trial show.

CHICAGO — Three months of dual antiplatelet therapy after PCI may safely balance thrombosis and bleeding risk in both patients with low and high bleeding risk, compared with 1 and 12 months of DAPT, according to new data.

A novel therapeutic showed significant promise in slowing aortic valve calcification, potentially extending time until or eliminating need for transcatheter or surgical intervention for stenosis, researchers reported.

In this Healio video exclusive, Jonathan H. Kim, MD, provides an overview of the recently published scientific statement on clinical considerations for participation of athletes with heart disease in competitive sports.